Emergent BioSolutions
EBS
$1.93
Share price
-1.03%
Change (1 day)
-79.64%
Change (1 year)
Categories
EPS for Emergent BioSolutions (EBS)
EPS in 2023 (TTM): -$12.08
According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -$12.08. In 2022 the company made an earnings per share (EPS) of -$4.48 a decrease over its 2021 EPS that were of $4.33.
EPS history for Emergent BioSolutions from 2004 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$12.08 | 169.64% |
| 2022 | -$4.48 | -203.46% |
| 2021 | $4.33 | -25.09% |
| 2020 | $5.78 | 445.28% |
| 2019 | $1.06 | -15.2% |
| 2018 | $1.25 | -35.9% |
| 2017 | $1.95 | 69.57% |
| 2016 | $1.15 | -27.67% |
| 2015 | $1.59 | 65.63% |
| 2014 | $0.96 | 11.63% |
| 2013 | $0.86 | 32.31% |
| 2012 | $0.65 | 1.56% |
| 2011 | $0.64 | -60.74% |
| 2010 | $1.63 | 59.8% |
| 2009 | $1.02 | 47.83% |
| 2008 | $0.69 | -12.66% |
| 2007 | $0.79 | -35.77% |
| 2006 | $1.23 | 59.76% |
| 2005 | $0.77 | 26.21% |
| 2004 | $0.61 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -115.40% | 🇺🇸 USA |
 Merck MRK | $1.82 | -115.08% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -128.98% | 🇬🇧 UK |
 Soligenix SNGX | -$2.66 | -77.99% | 🇺🇸 USA |
 SIGA Technologies SIGA | $0.38 | -103.15% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | -80.13% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -83.44% | 🇮🇱 Israel |